Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” first-quarter 2025 investor ...

The company has about 7,700 employees total, so the 5% layoff will likely hit more than 350 people overall. Anna Gralinska, a ...

Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” first quarter 2025 investor letter.

$80,000 of BIO-RAD LABORATORIES lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to biomedical research ...

In 2022, Bio-Rad walked away from talks to merge with competitor Qiagen. As first reported by the Wall Street Journal, people familiar with the matter stated that the aborted merger would have ...

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

Bio-Rad Laboratories, Inc.’s BIO Clinical Diagnostics business is back to its usual growth trajectory post-pandemic while maintaining a strong market position worldwide for key platforms.

TC20 Automated Cell Counter from Bio-Rad Whole Gel Eluter and Mini Whole Gel Eluter from Bio-Rad High Credibility: This website adheres to all nine standards of credibility and transparency.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX ™ Opus 96 Dx System and the CFX ™ Opus ...